"IDMPS will be an international, multicenter, observational study with a cross-sectional study to assess current practices in the management in the patients with type 1 and type 2 diabetes mellitus non-interventional on therapeutic strategy"

International Diabetes Management Practices Study - IDMPS

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2012/02/002407

Enrollment

12519

Registered

2012-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 1 and Type 2 Diabetes Mellitus Health Condition 2: E109- Type 1 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All male and female adult patients (who have attained majority) diagnosed with type 1 and type 2 DM ,visiting physician during the recruitment period of the cross-sectional study, up to the number of patients allocated to the physician. 2. Written Informed Consent

Exclusion criteria

Exclusion criteria: 1. Concomitant participation to a clinical trial 2. Previous participation in this study 3. Current temporary insulin therapy (gestational diabetes, surgery, pancreas cancer)

Design outcomes

Primary

Measure	Time frame
Primary Objective: To assess the therapeutic management of type 2 diabetic patients in the current medical practice.Timepoint: This is observational study. The outcome will be assessed at the time of statistical analysis, planned in Q4 2012	—

Secondary

Measure	Time frame
1. To assess the therapeutic management of type 1 diabetic patients in the current medical practice. 2. To assess the proportion of patients under the HbA1c threshold compared to the international recommendations. Timepoint: This is observational study. The outcome will be assessed at the time of statistical analysis, planned in Q4 2012	—

Countries

Algeria, Argentina, Cameroon, Colombia, Egypt, Georgia, India, Jordan, Kazakhstan, Lebanon, Morocco, Pakistan, Russian Federation, Saudi Arabia, Senegal, Tunisia, Turkey, Ukraine, United Arab Emirates, Uzbekistan, Venezuela (Bolivarian Republic of)

Contacts

Public ContactMs Gayatri Jaiswal

Sanofi Synthelabo (I) Ltd

gayatri.jaiswal@sanofi.com022-30707806

Outcome results